NCT06029088View on ClinicalTrials.gov

Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

616

Participants

Timeline

Start Date

January 12, 2023

Primary Completion Date

May 21, 2023

Study Completion Date

June 16, 2023

Conditions
Prostate CancerProstate Adenocarcinoma
Trial Locations (1)

06100

Ankara University School of Medicine, Ankara

All Listed Sponsors
lead

Ankara Etlik City Hospital

OTHER_GOV